Winston Pharmaceuticals, Inc. – Product Pipeline Review – 20

1. 2012 ||Product Pipeline|| Winston Pharmaceuticals, Inc. – Product Pipeline || Aarkstore.comhttp://www.aarkstore.com/reports/Winston-Pharmaceuticals-Inc-Product-Pipeline-Review-2012-236228.html You can also request for sample page of above mention reports on sample@aarkstore.com

2. Pages : 49PDF - $ 1500 | Site Licence - $ 3000 $ | Enterprise License - $ 4500 • 20% Off on above 1000$ Reports 25% off on purchase of 2 reports and 30% on purchase of 3 or more reports. • Discount till 31st Dec. 2012.

3. SummaryGlobal Market Direct’s pharmaceuticals report, “Winston Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Winston Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Winston Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Winston Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

4. Scope- Winston Pharmaceuticals, Inc. - Brief Winston Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Winston Pharmaceuticals, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Reasons to buy - Evaluate Winston Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.  - Assess the growth potential of Winston Pharmaceuticals, Inc. in its therapy areas of focus.  - Identify new drug targets and therapeutic classes in the Winston Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

5. Table Of Contents List of Tables 4List of Figures 4Winston Pharmaceuticals, Inc. Snapshot 5Winston Pharmaceuticals, Inc. Overview 5Key Information 5Key Facts 5Winston Pharmaceuticals, Inc. – Research and Development Overview 6Key Therapeutic Areas 6Winston Pharmaceuticals, Inc. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Winston Pharmaceuticals, Inc. – Pipeline Products Glance 10Winston Pharmaceuticals, Inc. – Late Stage Pipeline 10Registration Filed Products/Combination Treatment Modalities 10Phase III Products/Combination Treatment Modalities 11Winston Pharmaceuticals, Inc. Clinical Stage Pipeline Products 12Phase II Products/Combination Treatment Modalities 12Phase I Products/Combination Treatment Modalities 13…………….

6. Related Reports:Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 Actinium Pharmaceuticals, Inc. – Product Pipeline Review – 2012VakzineProjekt Management GmbH – Product Pipeline Review – 2012Torrent Pharmaceuticals Limited – Product Pipeline Review – 2012ViroMed Co., Ltd. – Product Pipeline Review – 2012Otsuka Holdings Co., Ltd. – Product Pipeline Review – 2012Suven Life Sciences Ltd. – Product Pipeline Review – 2012TrimelBioPharma SRL – Product Pipeline Review – 2012

7. For More details about above & other Reports plz contact :Lavanya Aarkstore.com Contact: Marketing team Mob.No.918149852585  Email: enquiry@aarkstore.com URL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore